{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:11:42Z","timestamp":1770819102691,"version":"3.50.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T00:00:00Z","timestamp":1412899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s11883-014-0459-4","type":"journal-article","created":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T05:40:33Z","timestamp":1412833233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Endovascular Versus Medical Therapy for Atherosclerotic Renovascular Disease"],"prefix":"10.1007","volume":"16","author":[{"given":"Mark Shipeng","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Folt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven T.","family":"Haller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Brewster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaleigh L.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,10]]},"reference":[{"issue":"1","key":"459_CR1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1310753","volume":"370","author":"CJ Cooper","year":"2014","unstructured":"Cooper CJ et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13\u201322. This is the primary report from the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL), a prospective randomized clinical trial. This trial compared patients receiving optimal medical therapy alone versus optimal medical therapy with stenting and concluded that stenting therapy does not provide more benefit than medical therapy alone.","journal-title":"N Engl J Med"},{"issue":"7","key":"459_CR2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2215\/CJN.11611113","volume":"9","author":"KL Evans","year":"2014","unstructured":"Evans KL et al. Use of renin-angiotensin inhibitors in people with renal artery stenosis. Clin J Am Soc Nephrol. 2014;9(7):1199\u2013206. This article reported the current ACEI\/ARB usage in patients with atherosclerotic renal artery stenosis from the CORAL trial. Although ACEI\/ARB usage has been shown to be beneficial in reducing mortality and morbidity in patients with ARVD, clinicians do not always prescribe ACEI\/ARBs to these patients.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"459_CR3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1067\/mva.2002.127351","volume":"36","author":"KJ Hansen","year":"2002","unstructured":"Hansen KJ et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36(3):443\u201351.","journal-title":"J Vasc Surg"},{"issue":"1","key":"459_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/ki.2009.406","volume":"77","author":"PA Kalra","year":"2010","unstructured":"Kalra PA et al. Atherosclerotic renovascular disease in the United States. Kidney Int. 2010;77(1):37\u201343.","journal-title":"Kidney Int"},{"issue":"7","key":"459_CR5","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/HJH.0b013e328329bbf4","volume":"27","author":"Q Mast de","year":"2009","unstructured":"de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J Hypertens. 2009;27(7):1333\u201340.","journal-title":"J Hypertens"},{"issue":"12 Pt 1","key":"459_CR6","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/00004872-199917120-00012","volume":"17","author":"M Johansson","year":"1999","unstructured":"Johansson M et al. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens. 1999;17(12 Pt 1):1743\u201350.","journal-title":"J Hypertens"},{"issue":"1","key":"459_CR7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1523-1755.2005.00406.x","volume":"68","author":"PA Kalra","year":"2005","unstructured":"Kalra PA et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005;68(1):293\u2013301.","journal-title":"Kidney Int"},{"issue":"7","key":"459_CR8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/01.CIR.98.7.642","volume":"98","author":"G Dorros","year":"1998","unstructured":"Dorros G et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98(7):642\u20137.","journal-title":"Circulation"},{"issue":"5","key":"459_CR9","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ajkd.2003.06.004","volume":"42","author":"DJ Kennedy","year":"2003","unstructured":"Kennedy DJ et al. Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. Am J Kidney Dis. 2003;42(5):926\u201335.","journal-title":"Am J Kidney Dis"},{"key":"459_CR10","first-page":"89","volume":"7","author":"HV Alderson","year":"2014","unstructured":"Alderson HV, Ritchie JP, Kalra PA. Revascularization as a treatment to improve renal function. Int J Nephrol Renov Dis. 2014;7:89\u201399.","journal-title":"Int J Nephrol Renov Dis"},{"issue":"6","key":"459_CR11","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1053\/ajkd.2001.24521","volume":"37","author":"RA Fatica","year":"2001","unstructured":"Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis. 2001;37(6):1184\u201390.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"459_CR12","first-page":"119","volume":"31","author":"JE Scoble","year":"1989","unstructured":"Scoble JE et al. Atherosclerotic renovascular disease causing renal impairment\u2014a case for treatment. Clin Nephrol. 1989;31(3):119\u201322.","journal-title":"Clin Nephrol"},{"issue":"1","key":"459_CR13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ki.1995.281","volume":"48","author":"RG Appel","year":"1995","unstructured":"Appel RG et al. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int. 1995;48(1):171\u20136.","journal-title":"Kidney Int"},{"issue":"1","key":"459_CR14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/CIRCULATIONAHA.106.637751","volume":"115","author":"H Guo","year":"2007","unstructured":"Guo H et al. Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation. 2007;115(1):50\u20138.","journal-title":"Circulation"},{"issue":"1","key":"459_CR15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2215\/CJN.03740907","volume":"3","author":"SR Orth","year":"2008","unstructured":"Orth SR, Hallan SI. Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients\u2014absence of evidence or evidence of absence? Clin J Am Soc Nephrol. 2008;3(1):226\u201336.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"20","key":"459_CR16","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa0905368","volume":"361","author":"K Wheatley","year":"2009","unstructured":"Wheatley K et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953\u201362.","journal-title":"N Engl J Med"},{"issue":"2","key":"459_CR17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40256-013-0011-x","volume":"13","author":"O Balafa","year":"2013","unstructured":"Balafa O, Kalaitzidis R, Siamopoulos KC. Optimal medical management in patients with renovascular hypertension. Am J Cardiovasc Drugs. 2013;13(2):71\u20138. A review of optimal medical management of ARVD with citation of current literature.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"6","key":"459_CR18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11883-014-0416-2","volume":"16","author":"CG Jennings","year":"2014","unstructured":"Jennings CG et al. Renal artery stenosis\u2014when to screen, what to stent? Curr Atheroscler Rep. 2014;16(6):416. A review article on the management of ARVD based on current literature.","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"459_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507\u201320. New guidelines for the management of high blood pressure in adults.","journal-title":"JAMA"},{"issue":"18","key":"459_CR20","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31822e80c3","volume":"124","author":"TW Rooke","year":"2011","unstructured":"Rooke TW et al. 2011 ACCF\/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124(18):2020\u201345.","journal-title":"Circulation"},{"issue":"7","key":"459_CR21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM198302173080706","volume":"308","author":"DE Hricik","year":"1983","unstructured":"Hricik DE et al. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med. 1983;308(7):373\u20136.","journal-title":"N Engl J Med"},{"issue":"2","key":"459_CR22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.HYP.22.2.237","volume":"22","author":"DH Sigmon","year":"1993","unstructured":"Sigmon DH, Beierwaltes WH. Renal nitric oxide and angiotensin II interaction in renovascular hypertension. Hypertension. 1993;22(2):237\u201342.","journal-title":"Hypertension"},{"issue":"6","key":"459_CR23","first-page":"770","volume":"63","author":"GC Gobe","year":"1990","unstructured":"Gobe GC, Axelsen RA, Searle JW. Cellular events in experimental unilateral ischemic renal atrophy and in regeneration after contralateral nephrectomy. Lab Invest. 1990;63(6):770\u20139.","journal-title":"Lab Invest"},{"issue":"1","key":"459_CR24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.HYP.0000022060.13995.ED","volume":"40","author":"H Tokuyama","year":"2002","unstructured":"Tokuyama H et al. Differential regulation of elevated renal angiotensin II in chronic renal ischemia. Hypertension. 2002;40(1):34\u201340.","journal-title":"Hypertension"},{"issue":"3","key":"459_CR25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ahj.2008.05.013","volume":"156","author":"DG Hackam","year":"2008","unstructured":"Hackam DG et al. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J. 2008;156(3):549\u201355. This article provides evidence regarding the benefit of ACEI\/ARB therapy in patients with renal artery stenosis.","journal-title":"Am Heart J"},{"issue":"4","key":"459_CR26","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/ndt\/gfr496","volume":"27","author":"C Chrysochou","year":"2012","unstructured":"Chrysochou C et al. Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease. Nephrol Dial Transplant. 2012;27(4):1403\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"459_CR27","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/ndt\/gfh865","volume":"20","author":"A Losito","year":"2005","unstructured":"Losito A et al. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant. 2005;20(8):1604\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"459_CR28","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1046\/j.1532-5415.2002.50321.x","volume":"50","author":"A Ahmed","year":"2002","unstructured":"Ahmed A. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine? J Am Geriatr Soc. 2002;50(7):1297\u2013300.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"459_CR29","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1523-1755.1998.00840.x","volume":"53","author":"PJ Ven van de","year":"1998","unstructured":"van de Ven PJ et al. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int. 1998;53(4):986\u201393.","journal-title":"Kidney Int"},{"issue":"14","key":"459_CR30","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jacc.2013.01.004","volume":"61","author":"JL Anderson","year":"2013","unstructured":"Anderson JL et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA guideline recommendations): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(14):1555\u201370. Current guideline on the management of peripheral artery disease.","journal-title":"J Am Coll Cardiol"},{"key":"459_CR31","first-page":"CD007784","volume":"2","author":"SD Navaneethan","year":"2009","unstructured":"Navaneethan SD et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2009;2:CD007784.","journal-title":"Cochrane Database Syst Rev"},{"issue":"25 Suppl 2","key":"459_CR32","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone NJ et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S1\u201345. Current guidelines on the management of blood cholesterol.","journal-title":"Circulation"},{"key":"459_CR33","first-page":"CD007784","volume":"5","author":"SC Palmer","year":"2014","unstructured":"Palmer SC et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2014;5:CD007784.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"459_CR34","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/ccd.21121","volume":"69","author":"MC Bates","year":"2007","unstructured":"Bates MC et al. Factors affecting long-term survival following renal artery stenting. Catheter Cardiovasc Interv. 2007;69(7):1037\u201343.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"459_CR35","doi-asserted-by":"crossref","first-page":"c35","DOI":"10.1159\/000107552","volume":"107","author":"CM Cheung","year":"2007","unstructured":"Cheung CM et al. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract. 2007;107(2):c35\u201342.","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"459_CR36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jvs.2009.05.019","volume":"50","author":"MA Corriere","year":"2009","unstructured":"Corriere MA et al. Restenosis after renal artery angioplasty and stenting: incidence and risk factors. J Vasc Surg. 2009;50(4):813\u20139. e1.","journal-title":"J Vasc Surg"},{"issue":"10","key":"459_CR37","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/ajh.2008.249","volume":"21","author":"VS Silva","year":"2008","unstructured":"Silva VS et al. Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease. Am J Hypertens. 2008;21(10):1163\u20138.","journal-title":"Am J Hypertens"},{"issue":"6","key":"459_CR38","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1681\/ASN.V561369","volume":"5","author":"DH Sigmon","year":"1994","unstructured":"Sigmon DH, Beierwaltes WH. Degree of renal artery stenosis alters nitric oxide regulation of renal hemodynamics. J Am Soc Nephrol. 1994;5(6):1369\u201377.","journal-title":"J Am Soc Nephrol"},{"key":"459_CR39","first-page":"CD005019","volume":"1","author":"SC Palmer","year":"2014","unstructured":"Palmer SC et al. HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database Syst Rev. 2014;1:CD005019.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"459_CR40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","volume":"353","author":"C Wanner","year":"2005","unstructured":"Wanner C et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353(3):238\u201348.","journal-title":"N Engl J Med"},{"issue":"14","key":"459_CR41","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","volume":"360","author":"BC Fellstr\u00f6m","year":"2009","unstructured":"Fellstr\u00f6m BC et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009;360(14):1395\u2013407.","journal-title":"N Engl J Med"},{"issue":"4","key":"459_CR42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1067\/mhj.2002.120769","volume":"143","author":"A Vashist","year":"2002","unstructured":"Vashist A et al. Renal artery stenosis: a cardiovascular perspective. Am Heart J. 2002;143(4):559\u201364.","journal-title":"Am Heart J"},{"issue":"2","key":"459_CR43","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ehj.2003.10.013","volume":"25","author":"C Patrono","year":"2004","unstructured":"Patrono C et al. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology. Eur Heart J. 2004;25(2):166\u201381.","journal-title":"Eur Heart J"},{"issue":"6","key":"459_CR44","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ccd.21932","volume":"73","author":"K Kanjwal","year":"2009","unstructured":"Kanjwal K et al. Complete versus partial distal embolic protection during renal artery stenting. Catheter Cardiovasc Interv. 2009;73(6):725\u201330.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"21","key":"459_CR45","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1161\/CIRCULATIONAHA.107.730259","volume":"117","author":"CJ Cooper","year":"2008","unstructured":"Cooper CJ et al. Embolic protection and platelet inhibition during renal artery stenting. Circulation. 2008;117(21):2752\u201360.","journal-title":"Circulation"},{"issue":"Suppl","key":"459_CR46","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1194\/jlr.R800059-JLR200","volume":"50","author":"A Chait","year":"2009","unstructured":"Chait A, Bornfeldt KE. Diabetes and atherosclerosis: is there a role for hyperglycemia? J Lipid Res. 2009;50(Suppl):S335\u20139.","journal-title":"J Lipid Res"},{"issue":"Suppl 2","key":"459_CR47","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.2337\/dc09-S339","volume":"32","author":"SR Heller","year":"2009","unstructured":"Heller SR. A summary of the ADVANCE trial. Diabetes Care. 2009;32 Suppl 2:S357\u201361.","journal-title":"Diabetes Care"},{"issue":"1","key":"459_CR48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/nyas.12044","volume":"1281","author":"F Giorgino","year":"2013","unstructured":"Giorgino F, Leonardini A, Laviola L. Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials. Ann N Y Acad Sci. 2013;1281(1):36\u201350. A summary of the current debate on glycemic control in type 2 diabetes and the potential benefit of strict glycemic control for some patients.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"459_CR49","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","volume":"358","author":"P Gaede","year":"2008","unstructured":"Gaede P et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580\u201391.","journal-title":"N Engl J Med"},{"issue":"15","key":"459_CR50","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMoa0806359","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359(15):1565\u201376.","journal-title":"N Engl J Med"},{"key":"459_CR51","unstructured":"Poredos P, et al. Medical management of patients with peripheral arterial disease. Int Angiol. 2014; A summary of current medical management of peripheral arterial disease."},{"issue":"1","key":"459_CR52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dc08-9026","volume":"32","author":"JS Skyler","year":"2009","unstructured":"Skyler JS et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009;32(1):187\u201392.","journal-title":"Diabetes Care"},{"issue":"24","key":"459_CR53","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Gerstein HC et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545\u201359.","journal-title":"N Engl J Med"},{"issue":"24","key":"459_CR54","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"Patel A et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560\u201372.","journal-title":"N Engl J Med"},{"issue":"2","key":"459_CR55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth W et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129\u201339.","journal-title":"N Engl J Med"},{"issue":"4","key":"459_CR56","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.1987.03390040114028","volume":"257","author":"AC Novick","year":"1987","unstructured":"Novick AC et al. Trends in surgical revascularization for renal artery disease: ten year\u2019s experience. JAMA. 1987;257(4):498\u2013501.","journal-title":"JAMA"},{"issue":"11","key":"459_CR57","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/archsurg.1981.01380230032005","volume":"116","author":"RH Dean","year":"1981","unstructured":"Dean RH et al. Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg. 1981;116(11):1408\u201315.","journal-title":"Arch Surg"},{"issue":"6","key":"459_CR58","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJM200102083440607","volume":"344","author":"RD Safian","year":"2001","unstructured":"Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344(6):431\u201342.","journal-title":"N Engl J Med"},{"issue":"2","key":"459_CR59","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jvs.2008.03.014","volume":"48","author":"JG Modrall","year":"2008","unstructured":"Modrall JG et al. Operative mortality for renal artery bypass in the United States: results from the national inpatient sample. J Vasc Surg. 2008;48(2):317\u201322.","journal-title":"J Vasc Surg"},{"issue":"4","key":"459_CR60","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1538574409335919","volume":"43","author":"JG Modrall","year":"2009","unstructured":"Modrall JG et al. Effect of hospital volume on in-hospital mortality for renal artery bypass. Vasc Endovasc Surg. 2009;43(4):339\u201345.","journal-title":"Vasc Endovasc Surg"},{"issue":"5","key":"459_CR61","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0741-5214(93)90340-R","volume":"18","author":"H Weibull","year":"1993","unstructured":"Weibull H et al. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg. 1993;18(5):841\u201350. discussion 850\u20132.","journal-title":"J Vasc Surg"},{"issue":"6","key":"459_CR62","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM200102083440603","volume":"344","author":"J Radermacher","year":"2001","unstructured":"Radermacher J et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344(6):410\u20137.","journal-title":"N Engl J Med"},{"issue":"2","key":"459_CR63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0272-6386(97)90027-5","volume":"29","author":"BA Greco","year":"1997","unstructured":"Greco BA, Breyer JA. Atherosclerotic ischemic renal disease. Am J Kidney Dis. 1997;29(2):167\u201387.","journal-title":"Am J Kidney Dis"},{"issue":"14","key":"459_CR64","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJM200004063421403","volume":"342","author":"BC Jaarsveld van","year":"2000","unstructured":"van Jaarsveld BC et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342(14):1007\u201314.","journal-title":"N Engl J Med"},{"issue":"1","key":"459_CR65","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-9343(02)01396-7","volume":"114","author":"AJ Nordmann","year":"2003","unstructured":"Nordmann AJ et al. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med. 2003;114(1):44\u201350.","journal-title":"Am J Med"},{"issue":"9149","key":"459_CR66","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0140-6736(98)04432-8","volume":"353","author":"PJ Ven van de","year":"1999","unstructured":"van de Ven PJ et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353(9149):282\u20136.","journal-title":"Lancet"},{"issue":"2","key":"459_CR67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.293.2.165","volume":"293","author":"A Kastrati","year":"2005","unstructured":"Kastrati A et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA. 2005;293(2):165\u201371.","journal-title":"JAMA"},{"issue":"4","key":"459_CR68","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/01.CIR.0000136580.34604.B8","volume":"110","author":"N Sawhney","year":"2004","unstructured":"Sawhney N et al. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation. 2004;110(4):374\u20139.","journal-title":"Circulation"},{"issue":"6","key":"459_CR69","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1540-8183.2004.04080.x","volume":"17","author":"H Storger","year":"2004","unstructured":"Storger H et al. Clinical experiences using everolimus-eluting stents in patients with coronary artery disease. J Interv Cardiol. 2004;17(6):387\u201390.","journal-title":"J Interv Cardiol"},{"issue":"4","key":"459_CR70","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1583\/1545-1550(2007)14[460:SVBLSF]2.0.CO;2","volume":"14","author":"M Zahringer","year":"2007","unstructured":"Zahringer M et al. Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years. J Endovasc Ther. 2007;14(4):460\u20138.","journal-title":"J Endovasc Ther"},{"issue":"1","key":"459_CR71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1358863X09106897","volume":"15","author":"TJ Kiernan","year":"2010","unstructured":"Kiernan TJ et al. Treatment of renal artery in-stent restenosis with sirolimus-eluting stents. Vasc Med. 2010;15(1):3\u20137.","journal-title":"Vasc Med"},{"issue":"3","key":"459_CR72","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ccd.21220","volume":"70","author":"T Zeller","year":"2007","unstructured":"Zeller T et al. Treatment of instent restenosis following stent-supported renal artery angioplasty. Catheter Cardiovasc Interv. 2007;70(3):454\u20139.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"459_CR73","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1148\/radiology.216.1.r00jl0778","volume":"216","author":"TC Leertouwer","year":"2000","unstructured":"Leertouwer TC et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology. 2000;216(1):78\u201385.","journal-title":"Radiology"},{"issue":"1 Pt 1","key":"459_CR74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0002-8703(00)90310-7","volume":"139","author":"MW Burket","year":"2000","unstructured":"Burket MW et al. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J. 2000;139(1 Pt 1):64\u201371.","journal-title":"Am Heart J"},{"issue":"14","key":"459_CR75","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.CIR.102.14.1671","volume":"102","author":"PS Watson","year":"2000","unstructured":"Watson PS et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000;102(14):1671\u20137.","journal-title":"Circulation"},{"issue":"1","key":"459_CR76","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/ajkd.2002.29881","volume":"39","author":"S Muray","year":"2002","unstructured":"Muray S et al. Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis. 2002;39(1):60\u20136.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"459_CR77","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2013.07.020","volume":"63","author":"J Ritchie","year":"2014","unstructured":"Ritchie J et al. High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization. Am J Kidney Dis. 2014;63(2):186\u201397. This article identifies a subgroup of high-risk patients with ARVD who may receive benefit from endovascular stenting therapy.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"459_CR78","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/ndt\/gfp623","volume":"25","author":"CM Cheung","year":"2010","unstructured":"Cheung CM et al. Effects of renal volume and single-kidney glomerular filtration rate on renal functional outcome in atherosclerotic renal artery stenosis. Nephrol Dial Transplant. 2010;25(4):1133\u201340.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"459_CR79","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/ndt\/gfr392","volume":"27","author":"C Chrysochou","year":"2012","unstructured":"Chrysochou C et al. BOLD imaging: a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular disease. Nephrol Dial Transplant. 2012;27(3):1013\u20139. This article identifies patients with ARVD who may benefit from endovascular interventional therapy.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"459_CR80","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/01.CIR.0000153271.77341.9F","volume":"111","author":"JA Silva","year":"2005","unstructured":"Silva JA et al. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation. 2005;111(3):328\u201333.","journal-title":"Circulation"},{"issue":"12","key":"459_CR81","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-150-12-200906160-00119","volume":"150","author":"L Bax","year":"2009","unstructured":"Bax L et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150(12):840\u20138. W150-1.","journal-title":"Ann Intern Med"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-014-0459-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-014-0459-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-014-0459-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T16:57:22Z","timestamp":1650387442000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-014-0459-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,10]]},"references-count":81,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["459"],"URL":"https:\/\/doi.org\/10.1007\/s11883-014-0459-4","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,10]]},"article-number":"459"}}